FDA Inspection 1223241 — Rising Pharma Holding, Inc.

Rising Pharma Holding, Inc. — FEI 3015784623

The FDA completed an inspection of Rising Pharma Holding, Inc. on Nov 3, 2023 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 3, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Brunswick, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.